路透首尔10月2日电---韩国食品安全机关周四表示，当局在新西兰进口的乳制品中发现微量三聚氰胺，并禁止其进口。该乳制品用于幼儿配方产品。
韩国食品药物管理局(Food and Drug Administration)在一份声明稿指出，该批含三聚氰胺的产品为新西兰Tatua Cooperative Diary Company生产的乳铁蛋白。声明稿并称，当局禁止该公司其他所有产品，且将进行进一步检验。
食品药物管理局称，19项幼儿配方产品并未发现有化学制剂，可能是因为添加物占最终产品比例不到0.1%的缘故。
目前尚无法取得Tauta的评论;由于产品中发现三聚氰胺，Tauta已经中止所有乳铁蛋白出口，该公司同时也在追踪产品出口流向，并试图找出三聚氰胺的污染源。
South Korea finds melamine in New Zealand product
SEOUL (Reuters) - South Korean authorities have found trace amounts of melamine in milk products imported from New Zealand that were used in baby formula and banned their import, its food safety agency said Thursday.
The Korea Food and Drug Administration said in a statement that the product, lactoferrin, was produced by Tatua Cooperative Diary Company of New Zealand. South Korea was banning all other products made by the company pending further tests, it said.
No trace of the chemical has been found in 19 baby formula products tested, presumably because the additive makes up less than 0.1 percent of the final product, the agency said.
No comment was immediately available from Tauta, which on Monday had suspended exports of lactoferrin because of the melamine find. The company was also checking where its product had been exported to and trying to trace the source of the melamine contamination.
"There's quite a lot of sensitivity around melamine even at low levels," chief executive Paul McGilvary told the NZ Press Association at the time.
He said the New Zealand Food Safety Authority had found fewer than four parts per million of melamine in the Tatua product, and found there was no contamination of the company's milk supply.
South Korea has banned the imports of Chinese milk powder and rice cookies produced in China. It has also recalled tainted products from store shelves.
A growing list of Chinese milk and milk-related products have been taken off shelves around the world in recent weeks after they have been found to be contaminated with the industrial chemical melamine, sickening tens of thousands and killing four children.
http://www.reuters.com/article/healthNews/idUSTRE4910UK20081002
